Besides, a study including 213 patients indicated that vitamin D deficiency or insufficiency was an independent risk factor for vascular access dysfunction in HD patients, treatment with VDR agonist ergocalciferol could alleviate AVF failure9. The gene discussed is VDR; the disease is vitamin D deficiency.